Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).


TSXV:MPH - Post by User

Comment by Philbert77on May 25, 2020 7:32pm
133 Views
Post# 31070975

RE:This ship is sinking!!

RE:This ship is sinking!!i dumped this today. What a sad story - there was so much potential when they sold Apicore. I thought big pile of money, they'd make some prudent decisions, what can go wrong? Then they wasted money on ReDS, then the huge buyback - which i got some cashed out but not enough... they are getting their lunch stolen by generics on AGGRASAT. I see no path to growth here. they blew all their money on crappy ReDS and a buyback and where do they go from here?

The crazy part is the CEO own a bunch of stock - like he has to be hurting on this as well...
So is he just incompetent?

A far better pharmaeutical company is Medexus - they are buying stuff that makes money and is actually growing earnings.. shocking! they are coming out of COVID-19 relatively unscathed and may even be more cashed up because they had to dial back some things because of COVID.
<< Previous
Bullboard Posts
Next >>